Oncoswab
Courroux, Switzerland
75% of lung cancer cases are detected too late. OncoSwab is changing that. Our mission: make early detection accessible with a non-invasive, easy-to-use test. Founded by visionary scientists and supported by the Health Wildcatters Accelerator, Swiss Government's DayOne Tech, and several pre-seed investors, OncoSwab is currently conducting a proof-of-concept trial with the collaboration of top US and European hospitals and lung cancer experts, aiming to save lives worldwide.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2023
- Website
- oncoswab.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Oncoswab?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now